Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 219Neoplasms 15Neoplasm Metastasis 12Carcinoma, Intraductal, Noninfiltrating 10Breast Neoplasms, Male 7Breast Diseases 7Breast Carcinoma In Situ 7Advanced Breast Cancer 6Triple Negative Breast Neoplasms 5Ovarian Neoplasms 5Endometrial Neoplasms 5Neoplasms by Site 3Breast Cancer Metastatic 3Uterine Cervical Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasm Female 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Seizures 1Sarcoma 1Recurrence 1Quality of Life 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteoporosis 1Multiple Endocrine Neoplasia Type 1 1Low Grade Serous Ovarian Cancer 1

Interventions

Levetiracetam 6Cannabidiol 4perampanel 2Standard of Care 2Everolimus 2enzalutamide 1Vigabatrin 1Tranexamic Acid 1Temozolomide 1Sodium Chloride 1Saline Solution 1Pregabalin 1Medical Marijuana 1Magnesium Sulfate 1Drug Therapy 1Curcumin 1Cholecalciferol 1Aspirin 1Anticonvulsants 1Anastrozole 1Airway Extubation 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Seizures × Anastrozole × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡